title: Multiplex analysis of cytokines/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings.
abstract: Differentiation of latent tuberculosis infection (LTBI) from active disease is one of the crucial elements in the control of tuberculosis. Earlier in Indian population which is tuberculosis endemic, we identified that 10 Mycobacterium tuberculosis secreted protein fractions, induced IFN-γ response only in healthy contacts of TB patients (HCs) and not in tuberculosis patients (TB). These fractions were termed as "Contact Specific Fractions" ("CS" fractions) and found useful for differentiating HC from TB. Proteomic analysis revealed that "CS" fractions have 16 different proteins, of which three were novel T cell antigens. Using these "CS" fractions as stimulants, earlier IFN-γ, TNF-α and IL-4 cytokine responses were studied. In the present study, in order to identify the other useful cytokine biomarkers that were differentially expressed between HC and TB, Cytokine/chemokine response to "CS" fractions were analyzed using multiplex cytokine assay system. This preliminary investigation in our tuberculosis endemic population showed six cytokine (G-CSF, IL-6, IL-7, IL-8, IL-9, and PDGF) and one receptor antagonist (IL-1Ra) that were differentially expressed between HC and TB, for the first time. Especially IL-6 and PDGF were more promising biomarkers. IL-6 measurement identified seven as HC out of 10 HC analyzed. The measurement of PDGF identified eight as TB out of 10TB tested. Studies are underway to further validate these biomarkers for the differentiation of LTBI from active tuberculosis.
authors: Department of Immunology, National Institute for Research in Tuberculosis, Mayor V.R. Ramanathan Road, Chetput, Chennai 600 031, India.
authors: D
authors: D
authors: Anbarasu
authors: C Ponnu
authors: CP
authors: Raja
authors: Alamelu
authors: A
authors: Raja
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D018925:Chemokines / Q000097:blood* / Q000378:metabolism; D019353:Endemic Diseases; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000097:blood / Q000378:metabolism; D006801:Humans; D007194:India / Q000453:epidemiology; D053590:Interleukin 1 Receptor Antagonist Protein / Q000097:blood / Q000378:metabolism; D055985:Latent Tuberculosis / Q000097:blood / Q000175:diagnosis* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010982:Platelet-Derived Growth Factor / Q000378:metabolism; D040901:Proteomics; D021241:Spectrometry, Mass, Electrospray Ionization; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
chemical_list: D015415:Biomarkers; D018925:Chemokines; D053590:Interleukin 1 Receptor Antagonist Protein; D010982:Platelet-Derived Growth Factor; D016179:Granulocyte Colony-Stimulating Factor